Oral Session 1-7C Multiple Myeloma: Multicenter Clinical Trials

[OS1-7C-5] A multicenter phase 2 study of VCD treatment for transplant-eligible multiple myeloma

Yukako Hattori^1,2, Ayumi Numata², Reina Watanabe², Tomonori Nakazato³, Hirotaka Takasaki², Yoshimi Ishii⁴, Kumiko Kishimoto^4,5, Taiki Ando⁴, Maki Hagihara⁴, Satomi Ito⁵, Hiroyuki Takahashi², Kazuho Miyashita⁴, Satoshi Koyama⁶, Hiroyuki Fujita⁵, Rika Sakai², Hideaki Nakajima⁶ (1.Department of Hematology/Oncology, Yamato Municipal Hospital, Yamato, Japan, 2.Department of Hematology and Medical Oncology, Kanagawa Cancer Center, 3.Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 4.Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan, 5.Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 6.Department of Hematology and Clinical Immunology, Yokohama City University Hospital)